HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Todd R Golub Selected Research
Todd R Golub Research Topics
Disease
84
Neoplasms (Cancer)
01/2024 - 01/2002
11
Breast Neoplasms (Breast Cancer)
11/2021 - 04/2004
11
Leukemia
12/2013 - 03/2002
10
Prostatic Neoplasms (Prostate Cancer)
04/2013 - 06/2003
8
Carcinogenesis
01/2018 - 04/2004
7
Neoplasm Metastasis (Metastasis)
11/2021 - 12/2005
6
Melanoma (Melanoma, Malignant)
11/2012 - 06/2002
5
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2016 - 10/2005
4
Glioma (Gliomas)
12/2022 - 12/2014
4
Neuroblastoma
01/2021 - 07/2008
4
Ewing Sarcoma (Sarcoma, Ewing)
11/2014 - 05/2002
3
Medulloblastoma
12/2023 - 01/2002
3
Residual Neoplasm
03/2023 - 01/2020
3
Triple Negative Breast Neoplasms
03/2023 - 06/2012
3
Starvation
02/2023 - 08/2002
3
Genomic Instability
01/2019 - 01/2014
3
Lung Neoplasms (Lung Cancer)
05/2015 - 06/2004
3
Fibrosis (Cirrhosis)
04/2014 - 07/2006
2
Microsatellite Instability
01/2023 - 11/2012
2
Brain Neoplasms (Brain Tumor)
01/2022 - 01/2021
2
Virus Diseases (Viral Diseases)
07/2017 - 01/2017
2
Adenocarcinoma
01/2017 - 01/2017
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2014 - 12/2011
2
Glioblastoma (Glioblastoma Multiforme)
12/2014 - 01/2009
2
Hepatocellular Carcinoma (Hepatoma)
04/2014 - 11/2008
2
Multiple Myeloma
01/2014 - 03/2011
2
Hepatitis C
05/2013 - 03/2009
2
B-Cell Lymphoma (Lymphoma, B Cell)
10/2010 - 08/2005
2
Hodgkin Disease (Hodgkin's Disease)
10/2010 - 08/2005
2
Heart Failure
04/2009 - 11/2007
2
Hematologic Neoplasms (Hematological Malignancy)
09/2008 - 08/2004
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2007 - 10/2006
2
Lymphoma (Lymphomas)
11/2007 - 08/2002
2
Myeloproliferative Disorders (Myeloproliferative Disorder)
07/2006 - 01/2005
2
Insulin Resistance
11/2002 - 05/2002
1
Inflammation (Inflammations)
10/2023
1
Ovarian Neoplasms (Ovarian Cancer)
01/2022
1
Uterine Neoplasms (Uterine Cancer)
01/2022
1
Aneuploidy (Aneuploid)
01/2021
Drug/Important Bio-Agent (IBA)
24
Proteins (Proteins, Gene)
FDA Link
01/2023 - 08/2002
14
MicroRNAs (MicroRNA)
IBA
01/2019 - 06/2005
13
DNA (Deoxyribonucleic Acid)
IBA
01/2023 - 08/2004
11
Transcription Factors (Transcription Factor)
IBA
12/2022 - 08/2003
8
Cell-Free Nucleic Acids
IBA
01/2024 - 11/2017
7
Messenger RNA (mRNA)
IBA
01/2022 - 06/2003
6
RNA (Ribonucleic Acid)
IBA
12/2023 - 12/2014
6
Enzymes
IBA
10/2023 - 03/2016
6
Androgen Receptors (Androgen Receptor)
IBA
05/2012 - 12/2004
5
ErbB Receptors (EGF Receptor)
IBA
05/2015 - 10/2009
5
Androgens
IBA
05/2012 - 12/2004
4
Small Interfering RNA (siRNA)
IBA
01/2019 - 12/2008
4
Biomarkers (Surrogate Marker)
IBA
01/2019 - 03/2010
4
Chromatin
IBA
01/2018 - 06/2002
4
Phosphotransferases (Kinase)
IBA
02/2012 - 12/2004
4
Prostate-Specific Antigen (Semenogelase)
IBA
06/2011 - 03/2002
3
Glucose (Dextrose)
FDA Link
Generic
02/2023 - 08/2002
3
Formaldehyde (Formol)
FDA Link
11/2022 - 11/2008
3
Cyclin-Dependent Kinases (cdk Proteins)
IBA
01/2020 - 07/2005
3
Cytokines
IBA
01/2019 - 07/2006
3
Estrogens (Estrogen)
FDA Link
01/2019 - 06/2008
3
Estrogen Receptors
IBA
01/2019 - 11/2007
3
Erlotinib Hydrochloride (CP 358,774)
FDA Link
04/2016 - 04/2014
3
Oncogene Proteins (Oncogene Protein)
IBA
10/2015 - 05/2002
2
prefoldin
IBA
12/2023 - 05/2023
2
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
10/2023 - 02/2008
2
Immune Checkpoint Inhibitors
IBA
10/2023 - 01/2020
2
Circulating Tumor DNA
IBA
03/2023 - 01/2023
2
Fatty Acids (Saturated Fatty Acids)
IBA
11/2021 - 01/2021
2
Cadherins (E-Cadherin)
IBA
12/2020 - 09/2009
2
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2019 - 02/2003
2
Histones (Histone)
IBA
01/2019 - 01/2018
2
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
01/2018 - 12/2014
2
Hormones (Hormone)
IBA
01/2017 - 03/2006
2
TOR Serine-Threonine Kinases
IBA
12/2014 - 06/2004
2
Reactive Oxygen Species (Oxygen Radicals)
IBA
07/2011 - 03/2008
2
Complementary DNA (cDNA)
IBA
06/2011 - 06/2008
2
Cyclin D1
IBA
02/2011 - 08/2003
2
Tyrosine (L-Tyrosine)
FDA Link
01/2009 - 09/2008
2
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2009 - 04/2005
2
Retinoids
IBA
07/2008 - 03/2002
2
Sirolimus (Rapamycin)
FDA Link
10/2006 - 08/2002
2
EWS-FLI fusion protein
IBA
05/2006 - 05/2002
2
Complement System Proteins (Complement)
IBA
05/2006 - 03/2005
2
Testosterone (Sustanon)
FDA Link
03/2006 - 12/2004
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
11/2002 - 05/2002
1
Micropeptides
IBA
12/2023
1
Protein Tyrosine Phosphatases
IBA
10/2023
1
TFX
IBA
03/2023
1
N-acetyltalosaminuronic acid (NAT)
IBA
03/2023
1
Phosphates (Orthophosphate)
IBA
01/2022
1
human ERBB2 protein
IBA
01/2021
1
Lipids
IBA
01/2021
1
Glycine (Aminoacetic Acid)
FDA Link
Generic
01/2021
1
Kinesins
IBA
01/2021
Therapy/Procedure
31
Therapeutics
10/2023 - 01/2002
4
Precision Medicine
01/2022 - 01/2019
3
Drug Therapy (Chemotherapy)
11/2017 - 01/2002
3
Ligation
04/2014 - 06/2008
1
Immunotherapy
10/2023
1
Neoadjuvant Therapy
03/2023